/
IVA
$3.55+$0.14 (+4.11%)live
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Market cap
$805.5M
236M shares
52-week range
$2.85 – $7.98
14% from low
Exchange
NASDAQ
ADRC
Price (6 mo)
Loading chart…
Change$-10.09
Inventiva S.A. American Depository Shares
Inventiva SA is a France-based clinical-stage biopharmaceutical company focused on the development of oral small-molecule therapies for the treatment of MASH. The wholly-owned research and development facility and a team with expertise and experience in the development of compounds that target nuclear receptors, transcription factors and epigenetic modulation. Leveraging the expertise, the company is also advancing lanifibranor for the treatment of MASH and has a pipeline of earlier-stage therapeutic programs in oncology. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France.
www.inventivapharma.com- Employees
- 77
- IPO / List date
- Jul 10, 2020
Held by traders on TradeandTell
No one on the platform currently holds IVA.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in IVA as of their last filing.
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded IVA yet.
